International Business Machines (IBM) 140.92 $IBM IBM,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
International Business Machines (IBM) 140.92 $IBM

IBM, UK STFC Hartree Centre, NVIDIA and Mellanox Launch High Performance Computing POWER Acceleration and Design Center for Business
PR Newswire - 2 mins ago
IBM (NYSE: IBM), in collaboration with NVIDIA and Mellanox, and the Science and Technology Facilities Council (STFC) Hartree Centre today announced plans for the UK's first POWER Acceleration and Design Center (PADC) designed to help UK businesses exploit high performance computing on OpenPOWER systems for Modelling & Simulation and Big Data Analytics.
IBM: 140.92 (+0.28)

Is Microsoft the Next BlackBerry?
at The Street - Wed Oct 21, 3:45PM CDT
Who's winning the operating system wars? It ain't Microsoft.
IBM: 140.92 (+0.28), BBRY: 7.08 (-0.12), GOOGL: 671.80 (-8.20), MSFT: 47.20 (-0.57), GOOG: 642.61 (-7.67), AAPL: 113.76 (-0.01), HPQ: 28.23 (-0.33), NOK: 6.94 (-0.02)

Another Biotech Sets Off More Selling
at The Street - Wed Oct 21, 3:10PM CDT
Market is feeling very jittery.
BLUE: 80.78 (+0.15), YHOO: 31.12 (-1.71), AMZN: 555.77 (-5.11), TSLA: 210.09 (-2.94), VRX: 118.61 (-28.13), SDS: 20.92 (+0.27), IBM: 140.92 (+0.28), FB: 97.11 (+0.11), CMG: 665.67 (-39.96), GM: 35.42 (+1.94), GOOGL: 671.80 (-8.20), BA: 141.19 (+2.31)

Microsoft Corporation Is Catching Up to Amazon.com Inc in the Cloud
Leo Sun, The Motley Fool - Motley Fool - Wed Oct 21, 3:00PM CDT
Amazon 's AWS (Amazon Web Services) is the established leader in cloud computing. The platform has 10 times the utilized capacity of its next 14 largest platform competitors combined, according to Gartner ...
AMZN: 555.77 (-5.11), GS: 179.70 (-5.81), IBM: 140.92 (+0.28), IT: 86.02 (-0.93), MSFT: 47.20 (-0.57), ORCL: 36.62 (-0.24)

New Zealand App Developer Overhauls Emergency Alert System on IBM Cloud
PR Newswire - Wed Oct 21, 1:00PM CDT
IBM (NYSE: IBM) announced that New Zealand-based application developer and emergency network provider, CLOUD M, has migrated its emergency alert tools and system to IBM Cloud for greater reliability and performance.
IBM: 140.92 (+0.28)

The Bears Retreat Again
at The Street - Wed Oct 21, 12:21PM CDT
The action is too strong to be aggressively bearish but too weak to be highly bullish.
YHOO: 31.12 (-1.71), AMZN: 555.77 (-5.11), TSLA: 210.09 (-2.94), SDS: 20.92 (+0.27), IBM: 140.92 (+0.28), FB: 97.11 (+0.11), CMG: 665.67 (-39.96), GM: 35.42 (+1.94), GOOGL: 671.80 (-8.20), BA: 141.19 (+2.31)

Introducing Neo4j on IBM POWER8
Marketwired - Wed Oct 21, 12:02PM CDT
GraphConnect -- Neo Technology, creator of Neo4j, the world's leading graph database, announced today its collaboration with IBM to offer Neo4j(R) on IBM POWER8(R). This collaboration offers a number of benefits to today's leading enterprises by combining real-time graph processing with the capabilities of IBM hardware to scale up and out like never before.
IBM: 140.92 (+0.28)

Jim Cramer -- 4 Companies, Same Problem, Different Strategies
at The Street - Wed Oct 21, 11:52AM CDT
IBM, Walmart, SanDisk and Yum! Brands don't have a lot in common beyond the problem of slowing growth, so no surprise, their CEOs are addressing the issue in disparate ways.
AMZN: 555.77 (-5.11), IBM: 140.92 (+0.28), WMT: 58.64 (-0.11), WDC: 71.44 (-3.42), SNDK: 76.78 (+1.59), YUM: 73.56 (+0.53)

Global Information Governance in Social Business 2015-2019- Market Analysis, Trends, and Forecast
M2 - Wed Oct 21, 10:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xngppr/global) has announced the addition of the "Global Information Governance in Social Business 2015-2019- Market Analysis, Trends, and Forecast" report to their offering. The global information governance in social business market to grow at a CAGR of 11.6% over the period 2014-2019. The report, Global Information Governance in Social Business Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. The volume of data at enterprise level is rising exponentially and is accentuated by the usage of third platform consisting of mobile, cloud, social media, and analytics. The need for managing information is not merely focused on records management but has become more complex because of growth of legal and regulatory requirements such as financial Dodd-Frank regulations. Similarly, legal establishments are becoming stricter with the standardization of documents and is leading to a rise in e-discovery requirements. Information governance has become a business imperative to reduce cost, extract value, mitigate risk, and increase revenues. The market is categorized broadly in two segments: software and services. This report covers information about the size of the global information governance in social business market by end-users. The report also covers information about the market based on geographies. Key vendors - Accenture - ASG Software - FTI Consulting - HP Autonomy - IBM - Iron Mountain Other prominent vendors - AABYY - CMO Software - EMC - Enablon - Exterro - Gimmal - Intelex Technologies - KCura - Metric Stream - Mega International - OpenText - Oracle - Resolver Key Topics Covered: Part 01: Executive summary Part 02: Scope of the report Part 03: Market research methodology Part 04: Introduction Part 05: Market landscape Part 06: Market segmentation by product Part 07: Market segmentation by end-user Part 08: Geographical segmentation Part 09: Market drivers Part 10: Impact of drivers Part 11: Market challenges Part 12: Impact of drivers and challenges Part 13: Market trends Part 14: Vendor landscape Part 15: Key vendor analysis Part 16: Appendix For more information visit http://www.researchandmarkets.com/research/xngppr/global
IBM: 140.92 (+0.28), IRM: 31.34 (-0.07)

What? Me Worry? The Answer Is Yes
at The Street - Wed Oct 21, 9:18AM CDT
Momentum is limited and the potential for bad news is growing.
YHOO: 31.12 (-1.71), AMZN: 555.77 (-5.11), TSLA: 210.09 (-2.94), SDS: 20.92 (+0.27), IBM: 140.92 (+0.28), CMG: 665.67 (-39.96), GOOGL: 671.80 (-8.20)

Stock Market News for October 21, 2015
Zacks Equity Research - Zacks Investment Research - Wed Oct 21, 9:10AM CDT
Benchmarks ended in the red on Tuesday, dragged down by declines in biotech and healthcare stocks
BIIB: 276.34 (+10.53), HOG: 47.03 (-1.22), IBM: 140.92 (+0.28), GILD: 101.73 (+0.07), UTX: 97.97 (+2.35), PFE: 33.46 (-0.54), MRK: 50.59 (+0.20), AMGN: 150.09 (-0.36), VZ: 44.86 (-0.38), REGN: 518.53 (+3.86), TRV: 110.70 (+1.75), CELG: 115.92 (-0.32)

Uganda's Infinity Computers Awards Services and Cloud Deal To IBM
PR Newswire - Wed Oct 21, 9:00AM CDT
Leading Ugandan IT services provider Infinity Computers has chosen IBM (NYSE: IBM) to deliver cloud, analytics and IT services to support a wide range of new web and mobile offerings for its clients.
IBM: 140.92 (+0.28)


Strong earnings from Boeing, GM, others send stocks higher
By The Associated Press - AP - Wed Oct 21, 8:39AM CDT
NEW YORK (AP) — Stocks are opening higher as several big U.S. companies deliver better earnings than the market was expecting.
LMT: 211.56 (+2.83), IBM: 140.92 (+0.28), WDC: 71.44 (-3.42), SNDK: 76.78 (+1.59), YUM: 73.56 (+0.53)

IBM Study: Customer Loyalty Shrinking For Banks at a Time When Relationships Matter Most
PR Newswire - Wed Oct 21, 8:34AM CDT
Bankers aren't doing as well as they think when it comes to customer trust, loyalty and creating a personalized banking experience. A new IBM (NYSE: IBM) study reveals there are serious gaps between how banking executives believe they are doing, and how their customers really feel. Among retail banking executives surveyed, 62 percent think they are delivering an excellent customer service but only 35 percent of retail customers agree -- a 27 percent gap.
IBM: 140.92 (+0.28)

BlueCava Announces Appointment of Bill Varga to Chief Revenue Officer
PR Newswire - Wed Oct 21, 8:00AM CDT
BlueCava, the leader in cross-screen marketing solutions, today announced that veteran software executive Bill Varga has joined the company as Chief Revenue Officer. Varga, an early pioneer in the audience targeting space with IP intelligence provider Quova (now Neustar) and CRM leader, SalesLogix (now Infor), most recently served as EVP Sales and Business Development at Ounce Labs (acquired by IBM) and was the go to market leader at Shunra Software (acquired by HP). Varga will lead BlueCava's expansion of global direct and indirect channels.
IBM: 140.92 (+0.28)

Triax Joins the IBM Watson Ecosystem
PR Newswire - Wed Oct 21, 8:00AM CDT
Triax Technologies, Inc and IBM announced today that Triax has joined the IBM Watson Ecosystem, enabling the development of new cognitive applications that Triax will create to help improve player health and safety related to concussive and sub-concussive impacts in sports. As part of the partnership, Triax will harness cognitive computing APIs from the Watson developer platform to help prevent head injuries by leveraging Personality Insights API to better understand an athlete's behavior. This announcement comes as both Triax and IBM participate in #SportsFest(TM) in Brooklyn, a three-day conference and exhibition celebrating the leading innovators in sports, technology and media.
IBM: 140.92 (+0.28)

Triple Play: IBM Scores Three All-Star Partnerships to Change the Game for Athletes, Fans Using Watson
PR Newswire - Wed Oct 21, 8:00AM CDT
IBM (NYSE: IBM) today announced partnerships with Triax TechnologiesTM, Spare5 and 113 Industries to develop cognitive applications powered by Watson that will help athletes train better, revolutionize golf training, amplify the game-day experience for fans and ultimately transform the future of sports. These organizations are part of a growing ecosystem of third-parties that are building applications, services and businesses embedded with cognitive technology in diverse industries and business disciplines including entertainment, retail, travel and hospitality, healthcare, financial services, legal, and education.
IBM: 140.92 (+0.28)

What Walmart's and IBM’s Troubles Really Tell Us About the U.S. Economy
at The Street - Wed Oct 21, 7:40AM CDT
Is the U.S. economy headed down again? Hardly.
TSLA: 210.09 (-2.94), AMZN: 555.77 (-5.11), GE: 28.85 (+0.07), FB: 97.11 (+0.11), WMT: 58.64 (-0.11), TM: 123.70 (+1.49), HPQ: 28.23 (-0.33), ORCL: 36.62 (-0.24), JNPR: 29.80 (-0.44), COF: 73.68 (-0.90), EQIX: 292.28 (-1.08), IBM: 140.92 (+0.28), RHT: 76.81 (-1.45), TGT: 76.40 (+2.00), MCD: 102.54 (-1.30), DG: 67.55 (+0.52), TWTR: 29.30 (-1.61)

The Bears Have More Ammunition to Work With
at The Street - Wed Oct 21, 5:40AM CDT
However, the price action doesn't confirm the bearish thesis.
YHOO: 31.12 (-1.71), AMZN: 555.77 (-5.11), TSLA: 210.09 (-2.94), IBM: 140.92 (+0.28), CMG: 665.67 (-39.96), GOOGL: 671.80 (-8.20)

Oct. 21 Premarket Briefing: 10 Things You Should Know
at The Street - Wed Oct 21, 5:37AM CDT
U.S. stock futures rise and shares in Japan move higher on hopes for fresh stimulus from the Bank of Japan.
KO: 42.19 (-0.10), BIIB: 276.34 (+10.53), AXP: 76.51 (-0.44), CS: 24.98 (-0.98), FCAU: 15.20 (-0.74), BA: 141.19 (+2.31), SBUX: 60.53 (-0.35), YHOO: 31.12 (-1.71), EBAY: 24.21 (-0.21), IBM: 140.92 (+0.28), LRCX: 70.79 (+0.76), TXN: 51.90 (-0.53), CMG: 665.67 (-39.96), GM: 35.42 (+1.94), EMC: 25.77 (-1.72), GOOGL: 671.80 (-8.20), KLAC: 63.98 (+10.12)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 40

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 273

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 240

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 167

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 0

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 121

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 120

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 184

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 208

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 135

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading

Top 5 Most Recently Viewed Articles

MAAS Embraces Healthcare with Strategic Carve Group Acquisition

Updated Category News Views 117

MAAS Expands into Healthcare and Wellness Maase Inc. (NASDAQ: MAAS) recently announced a significant expansion into the healthcare and wellness sector following its acquisition of Carve Group Ltd. This strategic move signifies MAAS's commitment to innovate within the traditional wellness product landscape by integrating advanced biotechnology. The acquisition is more than...

Continue Reading
Metavesco Welcomes ADHC's Strategic Purchase of OTCfi Tokens

Updated Category News Views 117

Metavesco Celebrates Collaboration with ADHC In a significant development, Metavesco, Inc. (NASDAQ: MVCO) recently expressed excitement over American Diversified Holdings Corporation (NASDAQ: ADHC) announcing their Digital Asset Treasury (DAT) purchase of OTCfi tokens. This partnership is seen as a positive move towards enhancing the visibility and growth of the...

Continue Reading
Understanding Short Interest Trends in Discover Financial

Updated Category News Views 188

Understanding Short Interest Trends in Discover Financial Discover Financial's stock ticker, DFS, has recently experienced an increase in its short interest, rising to 10.94% since the last report. The total number of shares sold short now stands at 3.11 million, equating to 1.42% of the available shares for trading. If we consider the current trading volume, it would...

Continue Reading
Immunic Reaches Key Milestone in Multiple Sclerosis Trials

Updated Category News Views 201

Immunic Completes Enrollment in Phase 3 Trials Immunic, Inc. (NASDAQ: IMUX), a pioneering biotechnology firm, recently reached a significant milestone by completing enrollment for its Phase 3 ENSURE trials, which focus on its lead drug, vidofludimus calcium. These trials target patients living with relapsing multiple sclerosis (RMS) and aim to evaluate the drug's...

Continue Reading
Ergonomic Apparel Revolution: Elevating Back Health in Daily Life

Updated Category News Views 86

Rising Trend of Ergonomic Posture Wear The growing trend of ergonomic apparel highlights the importance of posture-related health concerns. As people spend more time seated and engaged with screens, discomfort is becoming increasingly common. A recent review has brought attention to this phenomenon, shedding light on how ergonomic clothing can play a pivotal role in...

Continue Reading